scRNA-seq analysis shows neutrophil extracellular traps as drivers of obstruction-induced intestinal damage in rats Authors: Zhanchuan Li, Yongxin Ye, Peng Wang, Fei Long, Yingyi Zhang, Xunri Zheng, Changwei Lin, Xiaorong Li, Yang Bai, Yi Zhang Published: 2026 ABSTRACT Intestinal obstruction is a common surgical emergency characterised by rapid progression and high mortality. However, the underlying mechanisms remain incompletely elucidated. Here, we show, by combining single-cell RNA sequencing with in vivo pharmacological modulation in male rats, the temporal dynamics of neutrophil extracellular traps (NETs) formation and their contribution to barrier dysfunction in incarcerated small-bowel obstruction. Profiling of 23,320 intestinal cells reveals pronounced neutrophil infiltration in late-stage obstruction (24.59% of total cells) and enables identification of a discrete “NETs-associated neutrophil subset (Neu_NETs)”. These Neu_NETs exhibit marked transcriptional enrichment of IL-17, NF-κB and TNF signalling pathways. Functional analyses demonstrate a time-dependent accumulation of NETs within obstructed segments that inversely correlates with the expression of intestinal tight junction proteins. In vivo administration of the PAD4 inhibitor Cl-amidine significantly attenuates NETs formation, ameliorates histopathological injury, and decreases local levels of IL-1β and TNF-α. Therefore, targeting NETs may represent a strategy for treating intestinal obstruction. Introduction Intestinal obstruction is one of the most prevalent acute abdominal emergencies, representing approximately 15% of all admissions to acute abdominal surgical services and nearly 20% of emergency laparotomies. In the absence of timely intervention, intestinal obstruction can rapidly progress to transmural necrosis and intestinal perforation, precipitating systemic sepsis, shock, and death1,2. The pathophysiology of intestinal obstruction is now understood as a complex, multi-phase cascade encompassing mechanical luminal obstruction, mesenteric ischaemia, bacterial translocation, and an escalating systemic inflammatory response. Within this cascade, inflammatory disruption of the intestinal epithelial barrier is increasingly recognised as a pivotal determinant of clinical deterioration3–5. Nonetheless, the precise cellular and molecular mechanisms that orchestrate barrier failure remain incompletely defined. Consequently, elucidating the mechanistic underpinnings of intestinal obstruction and identifying more effective preventive and therapeutic strategies constitute pressing scientific priorities in this field. Neutrophils serve as pivotal early-effector cells of the innate immune system and exert context-dependent dual roles in inflammatory responses. In 2004, Brinkmann and colleagues first characterised NETs as a specialised antimicrobial defence mechanism employed by neutrophils6. These extracellular lattices consist of decondensed chromatin (DNA backbone) decorated with an array of antimicrobial effectors, including myeloperoxidase (MPO), citrullinated histone H3 (CitH3), neutrophil elastase (NE), calprotectin, and cathepsin G7–9. NETs are initiated when NADPH oxidase–derived reactive oxygen species (ROS) activate peptidyl-arginine deiminase 4 (PAD4), which catalyses the citrullination of histone arginine residues, thereby reducing their affinity for DNA and promoting chromatin decondensation10. Concurrently, calpain-1-mediated degradation of nuclear lamins triggers nuclear envelope rupture, permitting decondensed chromatin to spill into the cytoplasm. Subsequent granule-membrane disintegration releases granular enzymes such as MPO and NE, which further promote chromatin decondensation11. The resultant DNA–protein complex is then extruded into the extracellular milieu via either plasma-membrane rupture or vesicle-mediated exocytosis, forming NETs that entrap and kill extracellular pathogens while modulating inflammatory signalling. In recent years, numerous studies have shown that excessive NET formation may contribute to the pathogenesis of various infectious diseases and autoimmune disorders12,13.In sepsis, unrestrained neutrophil activation and exuberant NET release orchestrate a phenotypic switch in endothelial cells from an anti-inflammatory, anticoagulant state to a pro-inflammatory, pro-thrombotic state14. Concomitantly, NETs-associated proteases degrade the endothelial glycocalyx, increase microvascular permeability, and compromise endothelial barrier integrity, thereby accelerating septic progression15,16. In deep-vein thrombosis, NETs provide a structural scaffold that propagates thrombus formation through multiple complementary mechanisms, while simultaneously suppressing endogenous fibrinolysis and impeding thrombus dissolution17,18. In inflammatory bowel disease, NETs facilitate the translocation of luminal microbial constituents across the epithelial barrier into the underlying mucosa, triggering robust neutrophilic inflammation that further disrupts intestinal epithelial integrity19. Notably, Elrod et al. demonstrated in a peritoneal adhesion model that NETs serve as essential structural scaffolds for adhesion formation, and that DNase-mediated degradation of NETs significantly reduces peritoneal adhesions, suggesting that NETs may participate in the development of adhesive intestinal obstruction by promoting adhesion formation20. However, in the more acute pathological context of incarcerated intestinal obstruction—where obstruction is already established—whether NETs are involved in the progression of injury remains unclear. Using an incarcerated intestinal obstruction ligation model, the present study aims to investigate the expression dynamics of NETs and their relationship with intestinal injury after obstruction has already occurred, complementing the understanding of NETs’ role in the acute phase of intestinal obstruction. In this study, we combined scRNA-seq with in vivo pharmacological modulation to generate a time-resolved single-cell atlas demonstrating the progressive escalation of NETs formation during intestinal obstruction. Our data establish NETs generation as a pivotal dynamic event that drives disease progression. scRNA-seq resolved distinct Neu_NETs whose relative abundance increased in parallel with obstructive severity and displayed pronounced transcriptional enrichment of IL-17, NF-κB, and TNF inflammatory signalling cascades. Targeting the master NETs-forming enzyme PAD4 with the selective inhibitor Cl-amidine significantly attenuated NETs production, attenuated histopathological injury, restored intestinal barrier integrity as evidenced by preserved Occludin and Claudin-1 expression, and reduced local concentrations of IL-1β and TNF-α. Collectively, these findings reveal that pharmacological inhibition of NETs formation confers substantial protective effects in intestinal obstruction and identify PAD4-mediated NETs as a tractable therapeutic target for this high-morbidity condition. Results Single-cell landscape of intestinal tissue in rats with incarcerated intestinal obstruction Obstructed intestinal segments from sham-operated (Baseline), 2 h incarcerated (Early) and 6 h incarcerated (Advanced) rats were processed for scRNA-seq (Fig. 1A). After rigorous quality-control filtering, 23320 high-quality cells were retained—6825 from Baseline, 7439 from Early and 9056 from Advanced. TSNE visualisation resolved twelve major cell populations: T cells, B cells, plasma cells, goblet cells, enteroendocrine cells, Paneth cells, tuft cells, fibroblasts, lymphatic endothelial cells, macrophages, monocytes, and neutrophils (Fig. 1B). A heat map and bubble plot confirmed canonical marker-gene expression for each cluster (Fig. 1C–D). Quantitative comparison of cluster abundances revealed a marked reduction of T cells and Plasma cells and a reciprocal expansion of Monocytes and Neutrophils in the advanced stage. Notably, neutrophils exhibited the most pronounced expansion, with their relative abundance rising from baseline at 0 h to 1.22% at 2 h and reaching 24.59% by 6 h (Fig. 1E). These data demonstrate progressive neutrophil recruitment during incarcerated intestinal obstruction, underscoring their potential centrality in the evolving immune response.Fig. 1Single-cell landscape of intestinal tissue in rats with incarcerated intestinal obstruction.A Schematic workflow of single-cell RNA sequencing. B TSNE projection of major intestinal cell types isolated from incarcerated obstruction samples (total: 23320 cells; Baseline: 6825 cells; Early stage: 7439 cells; Advanced stage: 9056 cells). C Heat map depicting marker-gene expression levels across the identified cell types. D Bubble plot illustrating expression magnitude and prevalence of canonical marker genes for each cell type. E Relative abundance of each cellular cluster across the three experimental stages. Single-cell landscape of intestinal tissue in rats with incarcerated intestinal obstruction. A Schematic workflow of single-cell RNA sequencing. B TSNE projection of major intestinal cell types isolated from incarcerated obstruction samples (total: 23320 cells; Baseline: 6825 cells; Early stage: 7439 cells; Advanced stage: 9056 cells). C Heat map depicting marker-gene expression levels across the identified cell types. D Bubble plot illustrating expression magnitude and prevalence of canonical marker genes for each cell type. E Relative abundance of each cellular cluster across the three experimental stages. Hallmarks of incarcerated intestinal obstruction—intestinal inflammation and barrier disruption GO enrichment analysis comparing Baseline with Advanced stage revealed significant over-representation of pathways associated with the nucleus, inflammatory response, positive regulation of inflammatory response, structural constituents of the cytoskeleton, and actin cytoskeleton organization (Fig. 2A). KEGG analysis further demonstrated marked enrichment of pathways related to NETs formation, PI3K–Akt signalling, TNF signalling, NF-κB signalling, leucocyte transendothelial migration, and regulation of the actin cytoskeleton (Fig. 2B). Inflammation-associated GSEA of the top 30 significantly enriched pathways likewise revealed marked alterations in leucocyte chemotaxis, neutrophil migration, and leucocyte cell adhesion (Supplementary Fig. 1). In the sham group, the ileal mucosa exhibited a perfectly preserved architecture: the epithelium was orderly, without haemorrhage, necrosis, or inflammatory infiltrate. Villous epithelial cells displayed well-defined microvilli, with enterocytes and goblet cells arranged in a compact manner. Within the crypts, numerous Paneth cells were oriented apically toward the lumen, and a delicate capillary network was evident in the lamina propria (Chiu’s score 0). After 2 h of incarcerated intestinal obstruction, the ileal mucosa showed focal villous atrophy and surface irregularity. Crypt epithelium was hyperplastic, with distorted contours and active cryptitis. The lamina propria appeared oedematous, its interstitium widened, and capillaries were markedly dilated and congested. Scattered neutrophils and other inflammatory cells infiltrated the mucosa, and erythrocyte extravasation was noted at the lamina propria–epithelium interface; the submucosal loose connective tissue exhibited focal defects (Chiu’s score 3). At 6 h of obstruction, destruction was severe: villi were almost completely effaced, the surface epithelium showed extensive haemorrhage and dense inflammatory infiltration. Crypt architecture was severely distorted; only residual epithelium remained, crypt abscesses were frequent, goblet cells were virtually absent, and many crypts had vanished. The lamina propria and submucosa were flooded with erythrocytes and a mixed inflammatory infiltrate (Chiu’s score 5). Compared with sham controls, Chiu’s scores increased progressively with prolonged obstruction duration (Fig. 2C). Furthermore, immunohistochemical quantification revealed a progressive, time-dependent decline in intestinal tight-junction protein occludin expression relative to sham controls (Fig. 2D). ELISA analyses of obstructed intestinal homogenates and peripheral serum from rats with incarcerated obstruction demonstrated markedly elevated levels of the pro-inflammatory cytokines IL-1β and TNF-α in the advanced obstruction phase compared with sham (Fig. 2E). Collectively, these findings provide compelling evidence for the development of intestinal inflammation, activation of immune responses, and disruption of the epithelial barrier during obstruction. We therefore postulate that neutrophil infiltration and the ensuing inflammatory cascade play a pivotal role in barrier dysfunction during the progression of incarcerated intestinal obstruction.Fig. 2Hallmarks of incarcerated intestinal obstruction—intestinal inflammation and barrier disruption.A GO enrichment analysis of differentially expressed genes between Baseline and Advanced stage. B KEGG pathway analysis highlighting enriched NETs formation pathways in obstructed intestine. C Representative HE images and Chiu’s scores of obstructed intestinal tissues from sham, 2 h, and 6 h incarcerated obstruction groups. Scale bars = 100 μm (main images) and 50 μm (magnification insets of microscopy images). one-way ANOVA. N = 8, ****P < 0.0001. D For the sham operation group, the images and quantitative analysis of the tight junction protein Occludin in the obstructed intestinal tissues of rats with 2-h and 6-h incarcerated intestinal obstruction were conducted. Scale bars = 50 μm (main images) and 25μm (magnification insets of microscopy images).Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. E ELISA quantification of IL-1β and TNF-α levels in intestinal homogenates and peripheral serum of rats with incarcerated obstruction.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ***P < 0.001; ****P < 0.0001. Hallmarks of incarcerated intestinal obstruction—intestinal inflammation and barrier disruption. A GO enrichment analysis of differentially expressed genes between Baseline and Advanced stage. B KEGG pathway analysis highlighting enriched NETs formation pathways in obstructed intestine. C Representative HE images and Chiu’s scores of obstructed intestinal tissues from sham, 2 h, and 6 h incarcerated obstruction groups. Scale bars = 100 μm (main images) and 50 μm (magnification insets of microscopy images). one-way ANOVA. N = 8, ****P < 0.0001. D For the sham operation group, the images and quantitative analysis of the tight junction protein Occludin in the obstructed intestinal tissues of rats with 2-h and 6-h incarcerated intestinal obstruction were conducted. Scale bars = 50 μm (main images) and 25μm (magnification insets of microscopy images).Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. E ELISA quantification of IL-1β and TNF-α levels in intestinal homogenates and peripheral serum of rats with incarcerated obstruction.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ***P < 0.001; ****P < 0.0001. The heterogeneity of neutrophils during the pathological process of incarcerated intestinal obstruction Functional enrichment of NETs formation in incarcerated intestinal obstruction prompted a focused examination of neutrophils. After stringent filtering, 2318 high-quality neutrophils were retained and subjected to UMAP-based clustering, yielding nine distinct clusters (Fig. 3A–B). Using AddModuleScore, we calculated NETs-related gene module activity for each cluster. Clusters 2 and 3 exhibited the highest NET scores, which were statistically indistinguishable. Consequently, clusters 2 and 3 were designated as Neu_NETs. Examination of marker expression via dot plot revealed that clusters 4 and 7 lacked canonical neutrophil markers Csf3r and Cxcr2 (Fig. 3C–D). These clusters were therefore considered contaminating populations and excluded from subsequent analyses. Based on the relative NETs-associated gene module scores, the remaining neutrophil clusters were reclassified as Neu_2, Neu_3, Neu_4, and Neu_5 (Fig. 3E). Quantitative profiling revealed that Neu_3 and Neu_NETs represented 0% and 8.33% of total neutrophils in the Early stage, respectively, increasing to 8.36% and 38.1% in the Advanced stage (Fig. 3F). These data indicate a progressive expansion of both Neu_3 and Neu_NETs populations during obstructive evolution, implicating their pivotal roles in incarcerated intestinal obstruction. Subsequently, we explored the potential gene-related functions of different neutrophil subsets. We found that NET-associated neutrophils (Neu_NETs) highly express genes related to neutrophil activation and inflammation, such as S100a9, S100a8, Mmp8, Retnlg, and Ifitm6, which amplify inflammatory responses and contribute to tissue damage. The S100A8/S100A9 proteins expressed by Neu_NETs are calcium-binding proteins that play important roles in driving neutrophil migration, promoting the release of pro-inflammatory cytokines, and facilitating NETs formation. These proteins are well-established biomarkers of classical neutrophil activation and inflammation21–24. Previous studies have shown that S100A8/S100A9 promote reactive oxygen species (ROS) generation in neutrophils, thereby triggering cell death pathways that sustain NET-driven inflammatory cascades25,26. Concurrently, Mmp8 degrades collagenous extracellular matrix, facilitating neutrophil infiltration and enlarging the inflammatory focus27,28. In order to further validate the key “NETs-related neutrophils” (Neu_NETs) subpopulation identified by scRNA-seq, we employed RT-qPCR technology to measure the relative expression levels of mRNA for genes such as S100a9, S100a8, and Mmp8 in the intestinal tissues of the sham operation group and the 6-h incarcerated intestinal obstruction rat model group, as well as in the isolated neutrophils from the peripheral blood of the rats. The results showed that compared with the sham operation group, the expression levels of these genes were significantly increased in the 6-h incarcerated intestinal obstruction rat model (Fig. 3G–H). Since S100a8/a9 usually exists in a dimer form, we evaluated the number of S100A9+ neutrophils by preparing single-cell suspensions from the intestinal tissues and peripheral blood samples of the sham operation group and the 6-h incarcerated intestinal obstruction rat model group using flow cytometry. The results indicated that compared with the sham operation group, the proportion of S100A9+ neutrophils in the total neutrophils was significantly increased in the 6-h incarcerated intestinal obstruction rat model (Fig. 3I–J). Neu_3 cells highly express chemokine and pro-inflammatory mediator genes, such as Ccl6, Cxcl3, and Cxcl1. These cells recruit myeloid cells to the site of infection via Cxcl1/Cxcl3 signalling and activate macrophage antimicrobial functions through Ccl6, thereby facilitating rapid pathogen clearance and amplifying the inflammatory cascade29–31.Fig. 3Neutrophil heterogeneity.A UMAP projection of neutrophil clusters 0–8. B NETs-associated gene-module scores for clusters 0–8. C Dot plot showing canonical marker-gene expression across clusters 0–8. D UMAP visualization of re-defined neutrophil subsets: Neu_NETs, Neu_2, Neu_3, Neu_4, and Neu_5. E Dot plot illustrating marker-gene expression within each re-defined subset. F Relative proportions of neutrophil subsets in Early versus Advanced obstruction stages. G Relative mRNA expression levels of S100a9, S100a8, and Mmp8 genes in the intestinal tissues of rats with 6-h incarcerated intestinal obstruction in the sham operation group. Error bars: Mean ± SEM, t-tests. N = 5, ***P < 0.001; ****P < 0.0001. H Relative mRNA expression levels of S100a9, S100a8, and Mmp8 genes in the peripheral blood neutrophils of rats with 6-h incarcerated intestinal obstruction in the sham operation group. Error bars: Mean ± SEM, t-tests. N = 5, ****P < 0.0001. I Flow cytometry analysis of the proportion of S100A9+ neutrophils in the peripheral blood and intestinal tissues of rats in the sham operation group and those with 6-h incarcerated intestinal obstruction. J Flow cytometry analysis of the proportion of S100A9⁺neutrophils among all neutrophils in the peripheral blood and intestinal tissues of rats in the sham operation group and those with 6-h incarcerated intestinal obstruction. Error bars: Mean ± SEM, t-tests. N = 5, ****P < 0.0001. Neutrophil heterogeneity. A UMAP projection of neutrophil clusters 0–8. B NETs-associated gene-module scores for clusters 0–8. C Dot plot showing canonical marker-gene expression across clusters 0–8. D UMAP visualization of re-defined neutrophil subsets: Neu_NETs, Neu_2, Neu_3, Neu_4, and Neu_5. E Dot plot illustrating marker-gene expression within each re-defined subset. F Relative proportions of neutrophil subsets in Early versus Advanced obstruction stages. G Relative mRNA expression levels of S100a9, S100a8, and Mmp8 genes in the intestinal tissues of rats with 6-h incarcerated intestinal obstruction in the sham operation group. Error bars: Mean ± SEM, t-tests. N = 5, ***P < 0.001; ****P < 0.0001. H Relative mRNA expression levels of S100a9, S100a8, and Mmp8 genes in the peripheral blood neutrophils of rats with 6-h incarcerated intestinal obstruction in the sham operation group. Error bars: Mean ± SEM, t-tests. N = 5, ****P < 0.0001. I Flow cytometry analysis of the proportion of S100A9+ neutrophils in the peripheral blood and intestinal tissues of rats in the sham operation group and those with 6-h incarcerated intestinal obstruction. J Flow cytometry analysis of the proportion of S100A9⁺neutrophils among all neutrophils in the peripheral blood and intestinal tissues of rats in the sham operation group and those with 6-h incarcerated intestinal obstruction. Error bars: Mean ± SEM, t-tests. N = 5, ****P < 0.0001. Neutrophil subpopulation prediction function and prospective time-series analysis (Trajectory Inference, TI) Functional annotation of the identified neutrophil subsets by GO and KEGG analyses revealed distinct biological programmes. Neu_NETs were predominantly enriched for immune and inflammatory regulation, encompassing cytoskeletal reorganisation, cellular motility, and intercellular signalling. Neu_2 was associated with pattern-recognition receptor activity, including Toll-like, NOD-like, and other PRRs, that initiate and modulate inflammatory responses. Neu_3 was linked to immune homoeostasis, notably negative regulation of B-cell activation. Neu_4 was characterised by energy metabolism, with pathways involving ribosome biogenesis and oxidative phosphorylation. Neu_5 exhibited enrichment in neutrophil activation regulation, including phospholipase A2 activity and lipid catabolism that amplify inflammatory cascades (Fig. 4A–B).Fig. 4Neutrophil subpopulation prediction function and prospective time-series analysis.A GO enrichment analysis of each neutrophil subpopulation (B) KEGG enrichment analysis of each neutrophil subpopulation. C Pseudotime trajectory of neutrophil subsets generated by Monocle 2. D Pseudotime-dependent gene-expression clusters. E GO and KEGG enrichment analyses for genes within Cluster 1. Neutrophil subpopulation prediction function and prospective time-series analysis. A GO enrichment analysis of each neutrophil subpopulation (B) KEGG enrichment analysis of each neutrophil subpopulation. C Pseudotime trajectory of neutrophil subsets generated by Monocle 2. D Pseudotime-dependent gene-expression clusters. E GO and KEGG enrichment analyses for genes within Cluster 1. To further understand the differentiation of these neutrophil subsets, we applied Monocle 2 pseudotime analysis to delineate their developmental trajectories. Using this approach, the algorithm resolved seven transcriptional states distributed along three principal branches. Notably, Neu_2 cells mapped exclusively to the trajectory origin, whereas Neu_NETs were detected at late stages of both decision points 2 and 3. Furthermore, Neu_NETs appeared slightly earlier than Neu_3 along the branch emerging from decision point 2 (Fig. 4C). Consistent with the progressive increase in the proportions of Neu_NETs and Neu_3 during obstruction, these data suggest that both subsets may critically orchestrate the pathophysiological progression of incarcerated intestinal obstruction. Following the delineation of neutrophil subset trajectories, we examined genes temporally linked to developmental progression. Co-expressed genes were grouped into three pseudotime-dependent clusters. Cluster 1 exhibited a progressive up-regulation that coincided with the differentiation trajectories of Neu_NETs and Neu_3(Fig. 4D). GO enrichment of Cluster 1 revealed significant terms, including chemokine activity, immune response, extracellular region, extracellular space, and cellular response to interleukin-17. KEGG analysis further identified enrichment of the IL-17, NF-κB, TNF, NOD-like receptor, and chemokine signalling pathways (Fig. 4E). In summary, we speculate that the Cluster 1 gene group drives neutrophil differentiation into the Neu_NETs and Neu_3 functional subsets by synergistically activating inflammatory signalling pathways such as IL-17, NF-κB, and TNF. This process mediates their chemotactic recruitment and NETs formation, thereby amplifying the inflammatory cascade. Elevated NETs levels in intestinal lesions of rats with incarcerated intestinal obstruction Inflammatory-pathway GSEA of differentially expressed genes between Early and Advanced stage neutrophil subsets revealed that the top 30 significantly enriched pathways include neutrophil chemotaxis and response to interleukin 1 (Fig. 5A). KEGG pathway analysis likewise demonstrated pronounced enrichment of NETs formation during the progression of incarcerated intestinal obstruction (Fig. 5B). To quantify NETs dynamics, NETs levels were measured in both obstructed intestinal tissue and peripheral serum using a rat-specific NETs ELISA kit. NETs concentrations in intestinal tissue were significantly higher at 6 h than at 2 h or in sham controls (Fig. 5C). Immunofluorescent co-staining of MPO and CitH3 confirmed that NETs formation became progressively more prominent as obstruction time increased (Fig. 5D). Collectively, these data demonstrate a progressive elevation of NETs expression within the obstructed intestine that parallels disease duration, implicating NETs in the pathogenesis and progression of incarcerated intestinal obstruction.Fig. 5Elevated NETs levels in intestinal lesions of rats with incarcerated intestinal obstruction.A GSEA derived top 30 inflammation-associated pathways. B KEGG enrichment showing NETs formation pathways in obstructed intestine. C ELISA quantification of NETs in intestinal tissue and peripheral serum.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ns: not statistically significant; ***P < 0.001; ****P < 0.0001.D Representative immunofluorescence co-staining of MPO and CitH3 in tissue sections.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). Elevated NETs levels in intestinal lesions of rats with incarcerated intestinal obstruction. A GSEA derived top 30 inflammation-associated pathways. B KEGG enrichment showing NETs formation pathways in obstructed intestine. C ELISA quantification of NETs in intestinal tissue and peripheral serum.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ns: not statistically significant; ***P < 0.001; ****P < 0.0001.D Representative immunofluorescence co-staining of MPO and CitH3 in tissue sections.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). NETs actively mediate intestinal barrier dysfunction To dissect the impact of NETs on incarcerated intestinal obstruction, we subjected rats to the PAD4 inhibitor Cl-amidine (Fig. 6A). Gross anatomical inspection revealed distinct differences among groups. Sham-operated intestines maintained a normal morphology—pink, pliable, with conspicuous surface vasculature and no dilation or stenosis; luminal contents consisted of regular chyme or formed stool without retention. In a 6-h incarcerated obstruction, bowel segments were markedly thinned and distended, with tense walls exhibiting a dark-red colouration and punctate serosal haemorrhages. The lumen contained haemorrhagic fluid mixed with necrotic debris and emitted a foul odour. By contrast, intestines from 6 h obstructed rats treated with Cl-amidine displayed pronounced oedema, a glistening red-pink serosa, and smooth contours; the lumen contained yellowish, jam-like exudate without frank necrosis (Fig. 6B). HE-stained sections revealed that the sham ileum displayed neatly arrayed villi and intact epithelium free of haemorrhage, necrosis, or inflammation (Chiu’s score 0). In 6 h of incarcerated obstruction, villi were almost completely effaced, the mucosal surface was obscured by massive haemorrhage, submucosal vessels were ruptured with abundant extravasated erythrocytes and mixed leucocytes, and granular pink necrotic debris permeated the mucosa; crypts were distorted, goblet cells were lost, and cryptitis with abscess formation was prominent(Chiu’s score 5). In 6 h obstructed + Cl-amidine rats, the ileum exhibited only mild villous swelling and slight shortening, a largely intact epithelium with well-preserved absorptive and goblet cells. The modest submucosal vascular congestion and focal pericryptal haemorrhage, and mild crypt hyperplasia with reduced goblet cells and low-grade cryptitis, indicate substantial mucosal preservation(Chiu’s score 2). Compared with untreated 6 h obstruction, Cl-amidine significantly attenuated Chiu’s injury scores (Fig. 6C). ELISA demonstrated markedly elevated IL-1β and TNF-α in intestinal tissue and serum of 6 h obstructed rats; Cl-amidine treatment substantially reduced both cytokines, indicating mitigation of local inflammation (Fig. 6D, E). IHC showed that occludin and claudin-1 were markedly reduced in 6 h obstruction, whereas Cl-amidine restored their expression to near-sham levels, implicating NETs inhibition in the preservation of intestinal barrier integrity (Fig. 6F). ELISA quantification of NETs in intestinal tissue and peripheral serum revealed a marked reduction in NETs levels in the Cl-amidine group compared with untreated incarcerated obstruction, confirming effective NETs inhibition (Fig. 6G). Immunofluorescence co-staining of obstructed intestinal sections further demonstrated that NETs markers (MPO and CitH3) were significantly elevated in 6 h incarcerated obstruction versus sham controls, whereas Cl-amidine markedly attenuated their expression, corroborating NETs suppression (Fig. 6H). Collectively, these findings establish NETs inhibition as a pivotal strategy for limiting inflammatory infiltration and preserving intestinal barrier integrity in incarcerated obstruction, positioning NETs formation as a promising therapeutic target.Fig. 6NETs mediate intestinal barrier dysfunction.A Schematic of the experimental workflow for NETs inhibition in rats with incarcerated intestinal obstruction. B Gross anatomical appearance of obstructed intestinal segments from incarcerated obstruction rats. C Representative HE images of obstructed intestine and corresponding Chiu’s injury scores.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images).one-way ANOVA. N = 8, ****P < 0.0001. D ELISA quantification of IL-1β in intestinal tissue and peripheral serum.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ***P < 0.001;****P < 0.0001. E ELISA quantification of TNF-α in intestinal tissue and peripheral serum. Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. F Immunohistochemistry images and quantitative analysis of intestinal barrier proteins Occludin and Claudin-1.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. G ELISA quantification of NETs in intestinal tissue and peripheral serum. Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. H Representative immunofluorescence co-staining of MPO and CitH3 in intestinal sections.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). NETs mediate intestinal barrier dysfunction. A Schematic of the experimental workflow for NETs inhibition in rats with incarcerated intestinal obstruction. B Gross anatomical appearance of obstructed intestinal segments from incarcerated obstruction rats. C Representative HE images of obstructed intestine and corresponding Chiu’s injury scores.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images).one-way ANOVA. N = 8, ****P < 0.0001. D ELISA quantification of IL-1β in intestinal tissue and peripheral serum.Error bars: Mean ± SEM, one-way ANOVA. N = 8, ***P < 0.001;****P < 0.0001. E ELISA quantification of TNF-α in intestinal tissue and peripheral serum. Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. F Immunohistochemistry images and quantitative analysis of intestinal barrier proteins Occludin and Claudin-1.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. G ELISA quantification of NETs in intestinal tissue and peripheral serum. Error bars: Mean ± SEM, one-way ANOVA. N = 8, ****P < 0.0001. H Representative immunofluorescence co-staining of MPO and CitH3 in intestinal sections.Scale bars = 50 μm (main images) and 25 μm (magnification insets of microscopy images). Discussion Intestinal obstruction is a common cause of acute abdominal pain, with a complex pathophysiological process involving mechanical obstruction, intestinal ischaemia, bacterial translocation, and systemic inflammatory responses. Although previous studies have described various pathological features of intestinal obstruction, its precise pathogenic mechanisms remain incompletely understood3,32. In this study, we leveraged scRNA-seq combined with in vivo pharmacological intervention to systematically delineate the dynamics of NET formation and its role in intestinal barrier injury during incarcerated intestinal obstruction, providing a potential therapeutic target for the treatment of intestinal obstruction. This study found, using scRNA-seq, that neutrophils significantly infiltrated during the course of incarcerated intestinal obstruction, and their proportion increased with the prolongation of obstruction time, especially reaching 24.59% in the late obstruction stage (6 h). Based on these observations over time, we further investigated the relationship between NET formation and the progression of intestinal injury. In this study, we observed that at 2 h post-obstruction, despite limited NET formation, significant epithelial histological damage (Chiu’s score 3) and decreased tight junction protein Occludin expression were already evident. In contrast, significant NETs elevation occurred at 6 h post-obstruction, concomitant with more severe tissue injury. This temporal sequence raises the possibility that NETs may not be the initiating factor in early intestinal obstruction injury, but rather may play a promoting role in the later stages of damage progression. However, it must be emphasised that the current study’s experimental design cannot definitively establish whether NETs function as primary initiators or secondary amplifiers in injury progression. Previous studies have demonstrated that intestinal ischaemia can directly induce epithelial injury independent of inflammatory cell infiltration: hypoxic conditions activate hypoxia-inducible factors (HIF)IFs) and their downstream signalling pathways, directly downregulating tight junction proteins such as Occludin, Claudin-1, and ZO-1, thereby increasing intestinal epithelial permeability33–36. Therefore, reduced intestinal wall blood flow and local hypoxia resulting from mechanical obstruction are likely major factors in the initial intestinal barrier injury. Concurrently, accumulating evidence supports the notion that excessive NET formation can exacerbate intestinal injury through multiple mechanisms37. For example, in intestinal ischaemia-reperfusion injury, NETs can aggravate pre-existing intestinal damage through various mechanisms: NETs can induce necroptosis in intestinal epithelial cells by regulating the TLR4/RIPK3/FUNDC1 signalling axis and inhibiting mitophagy38; they can also exacerbate microcirculatory dysfunction by inducing ferroptosis in intestinal microvascular endothelial cells39. Furthermore, studies in inflammatory bowel disease have shown that excessive NET formation disrupts epithelial barrier integrity, promotes bacterial translocation, and amplifies inflammatory cascades40. These findings support that NETs contribute to the promotion of intestinal injury. It is important to emphasise that the experimental observations in the current study may reflect either NETs exacerbating damage or damaged tissue promoting NETs release, but the causal relationship between NETs and injury progression remains unclear. Future studies employing neutrophil-specific PAD4 conditional knockout mice, time-controlled NETs inhibition at different time points during obstruction, or in vitro co-culture systems to investigate whether hypoxia/reoxygenation-treated intestinal epithelial cells can directly activate neutrophils to form NETs, as well as neutrophil-intestinal epithelial cell co-culture systems to validate whether NETs can directly damage the intestinal epithelial barrier, will be essential to dissect the directionality and molecular mechanisms underlying this interplay. Therefore, although our findings highlight elevated NETs in intestinal obstruction and validate the feasibility of targeted intervention, the causal relationship between NETs and intestinal injury, as well as the underlying molecular mechanisms, will be the focus of our future research. We plan to address this important mechanistic question in our subsequent studies using the experimental designs described above. To further investigate the cellular basis of increased NET formation during the progression of incarcerated intestinal obstruction, we explored neutrophil heterogeneity and their differentiation trajectories. And our findings were compared with previously reported findings on neutrophil subgroups in the human circulatory system. Wigerblad et al. classified circulating human neutrophils into four transcriptional states (Nh0-Nh3), with the Nh0 subset characterised by high expression of S100A8, S100A9, and other genes associated with a less mature neutrophil state41. The “NET-associated neutrophil” (Neu_NETs) subset identified in our study also shows high expression of S100a8 and S100a9 genes, suggesting that it may originate from Nh0-like precursors in the circulation. However, distinct from homoeostatic Nh0 cells in healthy human peripheral blood, the Neu_NETs identified in rat obstructed intestinal tissue in our study have acquired enhanced NET-forming capacity, as evidenced by high expression of Mmp8 and enrichment of IL-17 and NF-κB signalling pathways. This comparison suggests that Neu_NETs may represent an activated state of neutrophils that acquire NET-forming capacity after infiltrating intestinal tissue in response to the local inflammatory microenvironment. Our study extends the investigation of neutrophils from circulatory homoeostasis to functional transformation following tissue injury, complementing the description of neutrophil heterogeneity in healthy states by Wigerblad et al. It should be noted that, due to species differences (human vs rat) and differences in sample origin (peripheral blood vs intestinal tissue), the above comparison is primarily based on qualitative gene expression analysis. Future studies using cross-species single-cell integration tools may enable a more systematic investigation of neutrophil state transitions between the circulation and tissues. In addition, this study identified multiple subgroups of neutrophils and found that the proportions of “NETs-related neutrophils” (Neu_NETs) and neutrophil group 3 (Neu_3) significantly increased during the progression of obstruction.Neu_NETs highly express genes associated with neutrophil activation and inflammation, including S100a9, S100a8, and Mmp8, which play critical roles in driving neutrophil migration, promoting the release of pro-inflammatory cytokines, and facilitating NETs formation. In contrast, Neu_3 highly expressed genes associated with chemokines and inflammatory mediators, including Ccl6 and Cxcl3, amplifying the inflammatory cascade by recruiting myeloid cells and activating macrophage antimicrobial functions. Further pseudotime trajectory analysis showed that Neu_NETs and Neu_3 were mainly distributed at the late stage of the inferred differentiation trajectory, suggesting their potentially important roles in the pathological progression of intestinal obstruction. Additional sequencing analysis revealed that the functional differentiation of Neu_NETs and Neu_3 was significantly enriched in key inflammation- and immune-regulatory pathways, including IL-17, NF-κB, and TNF signalling, which may mediate their chemotactic recruitment and NET formation, thereby amplifying the inflammatory cascade. These findings not only reveal dynamic changes in neutrophils during intestinal obstruction but also provide important insights into the cellular basis of NET formation. After identifying the Neu_NETs subpopulation as a potential source of NETs in the obstructed intestine, we examined the spatiotemporal dynamics of NET formation during the progression of intestinal obstruction. An interesting observation in our study was the discordance between tissue and serum NET levels at the early stage of obstruction: at 2 h post-obstruction, NETs were detectable in intestinal tissue homogenates but not in peripheral serum. This spatial-temporal distribution pattern likely reflects the dynamic process of neutrophil recruitment and NET formation during the initial phase of intestinal injury. Upon obstruction-induced ischaemia and tissue damage, circulating neutrophils are rapidly recruited from the peripheral blood to the affected intestinal segment through well-orchestrated processes of endothelial capture, transendothelial migration, and chemotaxis42,43. Once at the injury site, these infiltrated neutrophils become activated and begin forming NETs locally within the intestinal tissue. At this early 2-h post-obstruction stage, NET formation is confined to the tissue microenvironment, and these structurally anchored DNA-protein complexes have not yet been released into the circulation in sufficient quantities for systemic detection. Indeed, the presence of NETs in peripheral blood is generally considered indicative of more advanced or systemic pathological conditions44, which is largely consistent with our experimental findings: by 6 h post-obstruction—when tissue damage is more extensive and neutrophil infiltration has markedly increased (reaching 24.59% of total cells)—NETs become detectable in both tissue and serum, suggesting a possible transition from localized to systemic involvement. However, the absence of detectable NETs in serum at 2 h likely reflects the early phase of localised neutrophil recruitment and NET formation. In this study, we employed a pretreatment strategy (administering Cl-amidine 3 h before model induction) to investigate the role of NETs formation in the progression of intestinal obstruction. PAD4, as a key enzyme in NETs formation, was blocked before NETs could form, allowing us to effectively evaluate the overall contribution of NETs to the pathological process of intestinal obstruction. Our results demonstrated that inhibiting NET formation significantly attenuated late-stage tissue damage, restored intestinal barrier function, and reduced inflammatory responses. However, it is important to clarify that intestinal obstruction itself directly causes injury through mechanical blockage and ischaemia/hypoxia, and this component of injury exists independently. The protective effects observed with Cl-amidine pretreatment primarily reflect a reduction in NET-mediated additional injury, rather than the reversal of tissue damage directly caused by other factors, such as ischaemia/hypoxia. This interpretation is consistent with the observation that although the Chiu score in the Cl-amidine-treated group (2) was significantly improved compared to the untreated group (5), it did not fully return to the sham group level (0), further indicating that the baseline injury caused by obstruction itself was not completely eliminated. Therefore, our findings demonstrate that NETs participate in the intestinal obstruction injury process and that inhibiting NET formation can effectively attenuate this injury. However, whether NET inhibitors can reverse established tissue damage cannot be determined from the current study. Future research employing post-treatment strategies (administering inhibitors after obstruction onset) is needed to further investigate whether NETs can serve as a therapeutic target for reversing existing injury. While our findings demonstrate that inhibiting NET formation attenuates intestinal injury, several limitations of this study should be acknowledged. Firstly, the findings were primarily derived from animal models, and their relevance to human intestinal obstruction requires further clinical validation. Secondly, while the Neu_NETs subset was characterised, the precise regulatory mechanisms governing its function remain to be elucidated. Moreover, the regulatory mechanisms of NETs during intestinal obstruction, as well as the specific molecular pathways by which NETs affect intestinal barrier function, remain poorly understood. Future studies integrating spatial transcriptomics, proteomics, or organoid models could help define the interaction network between NETs and intestinal epithelial cells, and explore the potential of NET-associated biomarkers for clinical diagnosis and prognostic assessment. In this study, scRNA-seq analysis revealed the dynamic formation of NETs during incarcerated intestinal obstruction and their critical role in intestinal barrier injury. Inhibition of NET formation significantly alleviates inflammation and intestinal barrier dysfunction caused by intestinal obstruction, suggesting it is a potential therapeutic target for its treatment. In future studies, we will further elucidate the regulatory mechanisms underlying NETs formation and validate their translational potential in the clinic, aiming to provide more effective therapeutic strategies for patients with intestinal obstruction. Methods Rats To minimise potential variability associated with oestrous cycle-related hormonal fluctuations, only male rats were used in this study. Furthermore, this approach adheres to the established conventions of previous rat models of incarcerated intestinal obstruction, thereby facilitating direct comparison of our findings with existing literature. Male Sprague-Dawley (SD) rats with a body weight of 200–250 g and an age of 6–8 weeks were obtained from the Laboratory Animal Centre of Central South University (Changsha, China). Animals were maintained under specific-pathogen-free (SPF) conditions on a 12 h light/dark cycle and allowed ad libitum access to standard rodent chow and filtered tap water for one week prior to experimentation. All procedures complied with relevant regulatory standards and were approved by the Institutional Animal Care and Use Committee of Central South University (approval no. CSU-2024-0364). We have complied with all relevant ethical regulations for animal use. Model of incarcerated intestinal obstruction in rats Prior to surgery, the experimental animals had free access to food and drinking water. Rats were anaesthetised via intraperitoneal injection of pentobarbital sodium (P3761, Merck, Germany), using a 3% pentobarbital sodium solution at a dosage of 0.1–0.2 mL/100 g body weight. After anaesthesia, the rats were placed in a supine position. Abdominal hair was removed using a depilatory device, and the skin was disinfected with 0.5% povidone–iodine. A midline abdominal incision approximately 3 cm in length was made. The skin and abdominal wall muscles were incised layer by layer, and the space between the skin and the abdominal wall muscles was dissected. The terminal ileum, approximately 2 cm from the ileocecal valve, was exteriorised as the bowel segment to be incarcerated. The site of incarceration was selected and marked. The width of the bowel at the site of incarceration was measured as X, and the length of the hernial ring was set as Y = 0.8 × X. One end of the abdominal wall muscle incision was sutured with silk thread, and this suture point was designated as point A. Another full-thickness muscle suture was placed at point B on the abdominal wall incision, leaving a residual incision AB of length Y, thus forming a hernial ring of length Y. The selected terminal ileum was then eviscerated through the hernial ring, with approximately 6 cm of bowel protruding. The abdominal wall muscles were sutured with interrupted 2-0 silk sutures, and 2 mL of normal saline was injected into the peritoneal cavity. The subcutaneous space was fully dissected, and the eviscerated bowel was placed within this space, ensuring no compression on the eviscerated bowel after skin closure. The skin was then closed with continuous 2-0 silk sutures45,46. After the model was established, attention was paid to maintaining body temperature and providing water and food. Tissue and sample collection At 6 h post-model induction, all rats with incarcerated intestinal obstruction were deeply anaesthetised. Under terminal anaesthesia, the obstructed intestinal segment was immediately excised. One portion was homogenised in ice-cold lysis buffer to generate tissue homogenate supernatants for ELISA; the remainder was fixed in 4% paraformaldehyde for 24 h, paraffin-embedded, and sectioned at 4 µm for subsequent histological and immunofluorescence analyses. Whole blood was collected via abdominal aortic puncture to obtain serum. Upon completion of tissue harvesting, all animals were euthanised by exsanguination under deep anaesthesia, in accordance with institutional guidelines. NETs inhibition and experimental design To explore the role of NETs formation in incarcerated intestinal obstruction, rats were randomly assigned to three groups (n = 8 per group): (1) sham-operated control; (2) incarcerated intestinal obstruction; (3) incarcerated intestinal obstruction+NETs inhibitor. Cl-amidine (TargetMol, China; catalogue #T10831L) was dissolved in sterile saline and administered intraperitoneally at 50 mg/kg 3 h before the induction of incarcerated intestinal obstruction. 6 h after model establishment, the entire obstructed intestinal segment was carefully excised and photographed to document macroscopic changes. Histopathological analysis Four-micrometre paraffin sections were deparaffinised in xylene and rehydrated through graded ethanol washes. To assess histopathological alterations in obstructed intestinal tissue, haematoxylin-eosin staining (Servicebio, G1076) was performed according to the manufacturer’s protocol. Morphological changes were examined under an optical microscope, and intestinal damage was quantified using the validated Chiu score47; scoring criteria are summarised in Table 1.Table 1Intestinal tissue injury Chiu’s scoreScorePathological changes0Normal small intestinal epithelial villi.1Widening of the subepithelial space at the apex of the villi, accompanied by capillary stasis.2Apical subepithelial space of the small intestine villi expanded with moderate separation of the superior cortex and lamina propria.3Upper cortex on both sides of the small intestinal villi separated from the lamina propria, and the apical part of the villi was damaged.4Small intestine villi damage accompanied by lamina propria capillary exposure and increased inflammatory cells.5Lamina propria damage, bleeding and ulceration. Table 1Intestinal tissue injury Chiu’s scoreScorePathological changes0Normal small intestinal epithelial villi.1Widening of the subepithelial space at the apex of the villi, accompanied by capillary stasis.2Apical subepithelial space of the small intestine villi expanded with moderate separation of the superior cortex and lamina propria.3Upper cortex on both sides of the small intestinal villi separated from the lamina propria, and the apical part of the villi was damaged.4Small intestine villi damage accompanied by lamina propria capillary exposure and increased inflammatory cells.5Lamina propria damage, bleeding and ulceration. Intestinal tissue injury Chiu’s score Immunohistochemistry (IHC) Antigen retrieval was performed by heating sections in 20× Tris-EDTA buffer (pH 9.0; Servicebio, G1203, Wuhan, China) for 15 min. After blocking endogenous peroxidase with 3% H₂O₂, slides were incubated with 3% BSA for 30 min at room temperature. Primary antibodies were applied as follows: mouse anti-claudin-1 (1:1,000; Servicebio, GB15032) and rabbit anti-occludin (1:800; Servicebio, GB111401). Corresponding HRP-conjugated secondary antibodies—goat anti-mouse IgG (1:200; Servicebio, GB23301) and goat anti-rabbit IgG (1:200; Servicebio, GB23303)—were then used. Stained sections were examined and imaged on a Nikon E100 microscope (Nikon Corporation, Tokyo, Japan). Quantitative analysis was performed with ImageJ-Fiji v1.54p to determine the integrated optical density per unit area (IOD/Area)48. Immunofluorescence (IF) As previously described49, NETs were visualised by fluorescence microscopy. Obstructed intestinal tissues were incubated with primary antibodies against myeloperoxidase (1:500; Servicebio, GB15224) and citrullinated histone H3 (1:100, R2 + R8 + R17; Abcam, 5103). Secondary antibodies consisted of Cy3-conjugated goat anti-mouse IgG (1:300; Servicebio, GB21301) and Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:400; Servicebio, GB25303). DNA was counterstained with DAPI (Servicebio, G1012). Fluorescence images were acquired using an upright microscope (Nikon Eclipse C1, Nikon, Japan) and a slide scanner (Pannoramic MIDI, 3DHISTECH). Enzyme-linked immunosorbent assay (ELISA) Commercially available ELISA kits were used according to the manufacturers’ instructions to quantify NETs in intestinal tissue homogenate supernatants and peripheral blood serum (rat NETs ELISA kit, catalogue ADS-0020R1, Jiangsu Aidisheng Biological Technology Co., Ltd., Jiangsu, China), as well as the cytokines IL-1β and TNF-α (rat IL-1β ELISA kit, catalogue JL13202; rat TNF-α ELISA kit, catalogue JL20884, J&L Biological, Shanghai, China). Extracting neutrophils from the peripheral blood of rats Using heparin sodium anticoagulation tubes, 6 ml of abdominal aortic blood was collected from the rats in the sham operation group and the 6-h incarcerated intestinal obstruction model. According to the manufacturer’s instructions, neutrophils were isolated from the peripheral blood using the rat neutrophil extraction kit (Solarbio, P9200). Cell counting was performed using the SmartCell 600 automated cell counter (Mengwei, China)according to the manufacturer’s instructions. Real-time fluorescence quantitative PCR (RT-qPCR) Take 15–30 mg of fresh obstructed intestinal tissue and the peripheral blood neutrophils of rats as per the instructions of the rat neutrophil extraction kit mentioned above. Use the SteadyPure RNA Extraction Kit (Accurate Biotechnology, AG21024) to extract the total RNA from the obstructed intestinal tissue and the peripheral blood neutrophils of the rats. Reverse transcribe the mRNA into cDNA using Evo M-MLV RT Mix Kit (Accurate Biotechnology, AG11728). Dilute the product 5 times (1:4) without enzyme and use it as the template. Perform RT-qPCR amplification using 2×Universal SYBR qPCR Master Mix (Tolobio, #22204) on the LightCycler 480 fluorescence quantitative PCR instrument (Roche). Calculate the relative expression fold of the target gene using the 2^−ΔΔCt method. The primer sequences for the internal control and the target gene are shown in Table 2.Table 2Primer sequencePrimer namePrimer sequence(5’ → 3’)SA1009ForwardTAGCTTTGAGCAAGAAGATGGReverseCATACTTCCTAGAGTACTGATGGSA1008ForwardCTCTACAGGGATGACTTCAGGReverseTATTCTGCACAAACTGAGGGMmp8ForwardACTATGCTTACAGAGAACCCAReverseCTGAAGGTCCATAGATTGTCTGβ-actinForwardTGACAGGATGCAGAAGGAGAReverseTAGAGCCACCAATCCACACA Table 2Primer sequencePrimer namePrimer sequence(5’ → 3’)SA1009ForwardTAGCTTTGAGCAAGAAGATGGReverseCATACTTCCTAGAGTACTGATGGSA1008ForwardCTCTACAGGGATGACTTCAGGReverseTATTCTGCACAAACTGAGGGMmp8ForwardACTATGCTTACAGAGAACCCAReverseCTGAAGGTCCATAGATTGTCTGβ-actinForwardTGACAGGATGCAGAAGGAGAReverseTAGAGCCACCAATCCACACA Primer sequence Flow cytometry For the preparation of an intestinal tissue single-cell suspension, 1 cm segments of the obstructed intestinal parts were obtained from the sham operation group and the 6-h incarcerated intestinal obstruction rat model. The contents and mucus were washed off with pre-cooled PBS, and the segments were placed in 6-well plate culture dishes. The intestines were cut longitudinally, and the obstructed intestinal parts were cut into small fragments of about 1–3 mm³ using sterile scissors. Preheated enzymatic digestion solution was immediately added. The digestion solution contained 0.1% Collagenase I (Beyotime, Y296936), 0.1% Collagenase IV (Beyotime, Y296939), 0.1% Dispase II (Beyotime, ST2339), 7.5 µg/mL DNase I (AbMole, M31354), 5 mM CaCl₂ (Beyotime, ST365), and 1% FBS (Servicebio, G8003). The remaining volume was supplemented with RPMI 1640 medium (Gibco, 11875093). Digestion was then carried out at 37 °C in a shaking incubator for 30 min. Periodically, a pipette was used to assist in dispersion. RPMI 1640 medium containing 10% FBS was added to terminate the digestion. The digested mixture was subsequently filtered through a 70 µm cell sieve, and the filtrate was collected into a new centrifuge tube. The cells were washed with PBS buffer containing 10% FBS, centrifuged at 400 g for 5 min, and the supernatant was discarded. This step was repeated 2–3 times. Finally, the cell precipitate was resuspended in PBS to obtain a single-cell suspension. For the preparation of peripheral blood, a single-cell suspension, rat abdominal aortic blood was collected using a heparin sodium anticoagulant tube. Then an appropriate amount (100 µL) of whole blood was taken and added to a flow cytometry tube. 3 mL of red blood cell lysis solution (FineTest, K080) was added, and the mixture was allowed to stand at room temperature for 10 min. After centrifugation at 400 g for 5 min, the supernatant was discarded, and the cell precipitate was resuspended to obtain a single-cell suspension. After counting cells using a cell counting plate, the following antibodies were used for surface staining: PerCP-eFluor™710-CD11b/c (eBioscience™, 46-0110-80), HIS48-FITC (eBioscience™, 11-0570-82). After fixation and lysis (eBioscience™, #88-8824-00), PE-S100A9 (Cell Signalling, #93941) was added for incubation. Lysis buffer was used for the subsequent washing steps. Finally, flow cytometry was performed using a BD FACSCanto™ II flow cytometer according to the manufacturer’s protocol, and data were analysed using FlowJo v.10.8 software (BD Biosciences). The flow cytometry gating strategy is presented (Supplementary Fig. 2). Single-cell suspension preparation Specimens were obtained from three experimental groups: sham-operated controls (Baseline), 2 h incarcerated intestinal obstruction (Early stage), and 6 h incarcerated intestinal obstruction (Advanced stage). Immediately after harvest, obstructed intestinal segments were rinsed twice in ice-cold PBS, minced into 1–2 mm³ fragments in a sterile Petri dish, and transferred to 5 mL tubes preloaded with 2.5 mL of the Lamina Propria Dissociation Kit (Miltenyi Biotec, 130-097-410). Tubes were inverted five times, then incubated at 37 °C with orbital shaking (100 rpm) for 20 min. After gentle trituration with a Pasteur pipette (5–10 strokes), a 10 µL aliquot was removed to confirm tissue dissociation on a Countstar counter. The entire suspension was sequentially passed through 40 µm and 70 µm-30 µm cell strainers, collected into fresh tubes, washed with 4 mL ice-cold PBS, and centrifuged at 300 g, 4 °C, 5 min. Supernatants were discarded, and pellets were resuspended in 1-5 mL 1× RBC Lysis Buffer (Miltenyi Biotec, 130-094-183) according to erythrocyte content, incubated 5 min at room temperature, then centrifuged at 500 g, 4 °C, 5 min. After two washes with 5 mL ice-cold PBS (500 g, 4 °C, 5 min each), cells were resuspended in PBS + 0.04% BSA at 500–1500 cells/µL and kept on ice. Viability (≥80%), doublet rate (≤30%), nucleated-cell purity (≥65%), concentration (500–1500 cells/µL), and total cell number (≥50000) were verified on a Countstar Rigel S2 automated fluorescence analyser prior to loading onto the 10X Genomics Chromium platform. Chromium 10× genomic library preparation and sequencing Single-cell suspensions were loaded into a Chromium 10× Controller (10× Genomics) using the Chromium Single-Cell 3’ Reagent Kit v3 according to the manufacturer’s protocol, targeting recovery of 8000 cells. Following GEM generation, barcoded cDNA was amplified, and sequencing libraries were constructed following the standard workflow. Libraries were sequenced on an Illumina NovaSeq 6000 instrument (LC-Bio Technology, Hangzhou, China) in paired-end 150 bp mode to a minimum depth of 20000 reads per cell. Data quality control Raw Illumina base-call files were demultiplexed and converted to FASTQ format using bcl2fastq v2.20. Each FASTQ set was processed with the 10× Genomics Cell Ranger pipeline (v3.1.0; https://support.10xgenomics.com/single-cell-gene-expression) against the mRatBN7.2 reference genome. After stringent filtering, 33363 high-quality cells were retained across the three experimental stages (Baseline, Early, and Advanced), with 9446-13113 cells per sample and a median of 954-1066 genes detected per cell. Downstream analyses were performed in Seurat v4.0. Quality-control thresholds were: (1) genes per cell ≥500, (2) UMI counts not exceeding the upper limit defined by the Cell Ranger knee plot, (3) mitochondrial gene expression < 25%, and (4) putative doublets removed with DoubletFinder. These criteria yielded 6825-9056 high-confidence cells per sample for all subsequent analyses. Data integration, transformation, and normalization Dimensionality reduction and visualisation of the 23320 quality-filtered cells were performed in Seurat v4.0, yielding t-distributed stochastic neighbour embedding (t-SNE) maps. The workflow comprised four sequential steps: (1) Normalisation: raw UMI counts were log-normalised using the LogNormalise function in Seurat:NormalizeData after exclusion of low-quality cells. (2) Principal component analysis (PCA): the normalised expression matrix was subjected to PCA; the first 20 principal components, selected on the basis of elbow-plot inspection and JackStraw resampling, were retained for downstream analyses. (3) Cells were clustered with the shared-nearest-neighbour (SNN)-based FindCluster function implemented in Seurat. Differentially expressed marker genes among the resulting clusters were identified using the Seurat::FindAllMarkers tool, applying a bimodal likelihood-ratio test under the following criteria: detected in≥10% of cells within either the target cluster or the complementary population, and log2FC ≥ 0.26. Neutrophil heterogeneity To dissect the mechanistic contribution of neutrophils in incarcerated intestinal obstruction, we first subjected the neutrophil compartment to dedicated dimensionality reduction and clustering. Differentially expressed genes (DEGs) defining each neutrophil subpopulation were identified with FindAllMarkers. A NETs-associated transcriptional score was calculated for every subpopulation using the AddModuleScore function and employed to annotate NETs-related states. The functional relevance of the DEGs was interrogated using GO and KEGG enrichment analyses. Neutrophil trajectory inference To temporally position the identified neutrophil subsets along the disease continuum, pseudo-time trajectories were reconstructed with Monocle2 (v2.12.0). The “plot_pseudotime_heatmap” function was then applied to extract gene clusters that exhibit coherent expression dynamics across the inferred pseudo-time axis. Statistical analysis and reproducibility All data were analysed and visualised using GraphPad Prism 10.5.0. The data all represent mean ± SEM. Comparisons between two groups were performed using two-tailed unpaired Student’s t-test. For multiple group comparisons, one-way analysis of variance (ANOVA) was used, followed by Dunnett’s post hoc test for comparisons against a single control group. Each group contained at least three independent biological replicates (N = number of replicates), which were derived from separate animals or independent experiments. P < 0.05 was considered statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns: not statistically significant). Reporting summary Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article. Supplementary information Supplementary Information Reporting Summary Supplementary Information Reporting Summary